What is the official website of Bioexpression & Fermentation Facility ?

The official website of Bioexpression & Fermentation Facility is http://bff.uga.edu.

What is Bioexpression & Fermentation Facility's cybersecurity risk score?

Bioexpression & Fermentation Facility has an AI-generated cybersecurity risk score of 751 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Bioexpression & Fermentation Facility experienced?

According to Rankiteo, Bioexpression & Fermentation Facility currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Bioexpression & Fermentation Facility been affected by any supply chain cyber incidents ?

According to Rankiteo, Bioexpression & Fermentation Facility has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Bioexpression & Fermentation Facility have SOC 2 Type 1 certification ?

According to Rankiteo, Bioexpression & Fermentation Facility is not certified under SOC 2 Type 1.

Does Bioexpression & Fermentation Facility have SOC 2 Type 2 certification ?

According to Rankiteo, Bioexpression & Fermentation Facility does not hold a SOC 2 Type 2 certification.

Does Bioexpression & Fermentation Facility comply with GDPR ?

According to Rankiteo, Bioexpression & Fermentation Facility is not listed as GDPR compliant.

Does Bioexpression & Fermentation Facility have PCI DSS certification ?

According to Rankiteo, Bioexpression & Fermentation Facility does not currently maintain PCI DSS compliance.

Does Bioexpression & Fermentation Facility comply with HIPAA ?

According to Rankiteo, Bioexpression & Fermentation Facility is not compliant with HIPAA regulations.

Does Bioexpression & Fermentation Facility have ISO 27001 certification ?

According to Rankiteo,Bioexpression & Fermentation Facility is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Bioexpression & Fermentation Facility operate in ?

Bioexpression & Fermentation Facility operates primarily in the Biotechnology Research industry.

How many employees does Bioexpression & Fermentation Facility have ?

Bioexpression & Fermentation Facility employs approximately None employees people worldwide.

Does Bioexpression & Fermentation Facility own any subsidiaries ?

Bioexpression & Fermentation Facility presently has no subsidiaries across any sectors.

How many LinkedIn followers does Bioexpression & Fermentation Facility have ?

Bioexpression & Fermentation Facility's official LinkedIn profile has approximately 418 followers.

What is the NAICS classification code for Bioexpression & Fermentation Facility ?

Bioexpression & Fermentation Facility is classified under the NAICS code 541714, which corresponds to Research and Development in Biotechnology (except Nanobiotechnology).

Does Bioexpression & Fermentation Facility have a Crunchbase profile ?

No, Bioexpression & Fermentation Facility does not have a profile on Crunchbase.

Does Bioexpression & Fermentation Facility have a LinkedIn profile ?

Yes, Bioexpression & Fermentation Facility maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/uga-bioexpression-&-fermentation-facility.

How many cybersecurity incidents has Bioexpression & Fermentation Facility experienced ?

As of July 23, 2026, Rankiteo reports that Bioexpression & Fermentation Facility has not experienced any cybersecurity incidents.

How many peer or competitor companies does Bioexpression & Fermentation Facility have ?

Bioexpression & Fermentation Facility has an estimated 4,731 peer or competitor companies worldwide.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

BFF

Boost Score +25 with badge (5 left)

751

/1000

Fair

776

/1000

Fair

Bioexpression & Fermentation Facility Vendor Cyber Rating & Cyber Score

uga.edu

Add Your Compliance Badge

The Bioexpression & Fermentation Facility (BFF) at the University of Georgia (UGA) provides state of the art equipment and wide ranging expertise in the areas of fermentation, protein/peptide/DNA purification, mammalian cell culture & monoclonal antibodies. BFF has fermentation and processing capacity from 750mL – 750L, transient gene expression in HEK lines up to 25L, purification capability up to the 25L packed column level, as well as the ability to generate monoclonal antibodies against the produced proteins in a “one stop shop” facility.

BFF A.I CyberSecurity Scoring

Scoring History

BFF

Bioexpression & Fermentation Facility CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

BFF Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for BFF

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Bioexpression & Fermentation Facility in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Bioexpression & Fermentation Facility in 2026.

Incident Types BFF vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Bioexpression & Fermentation Facility in 2026.

Incident History - BFF (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Bioexpression & Fermentation Facility Subsidiaries

BFF

Biotechnology Research

Website: http://bff.uga.edu

Company Size: None employees

Innovation @ UGAResearch

The University of GeorgiaHigher Education

University of Georgia Warnell School of Forestry and Natural ResourcesHigher Education

University of Georgia OnlineHigher Education

Master of Biomanufacturing and BioprocessingBiotechnology

Loading…

Bioexpression & Fermentation Facility Similar Companies

Avantor

cb avantorsciences.com

Avantor® is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. Our global footprint enables us to serve more than 300,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world. More than 14,500 strong, our associates are passionate about our mission to set science in motion to create a better world. We share enthusiasm for innovation, excellence, and achievement. Whether we are collaborating with our customers to advance science or solve multifaceted problems, we help them reach their goals more efficiently and effectively. Visit our website to learn more about Avantor.

Gilead Sciences

cb gilead.com

At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy health inequities and break down barriers to care. We empower our people to tackle these challenges, and we’re all united in our commitment to help millions of people live healthier lives. Social Media Guidelines: https://www.gilead.com/social-media-guidelines

Roche

cb roche.com

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI). For more information, please visit https://careers.roche.com Read our community guidelines here: https://www.roche.com/some-guidelines.htm #Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalisedHealthcare #GreatPlaceToWork #Innovation

The National Institutes of Health

cb nih.gov

NIH is the only agency of its kind. We impact the health of the country and the world through unique and innovative medical research. Did you know that NIH is the largest public funder of biomedical research in the world, investing more than $32 billion a year to enhance life, and reduce illness and disability? NIH funded research has led to breakthroughs and new treatments, helping people live longer, healthier lives, and building the research foundation that drives discovery. Whether you are graduating with a bachelor's degree, working on your doctoral degree, entering the workforce for the first time, or changing careers, NIH offers a place for you to start and plenty of room to grow your career. When you join us, you’re not just advancing your career — you’re driving the health of our country forward. Official LinkedIn Account of the NIH. Privacy policy: http://go.usa.gov/x9svN Comment policy: https://bit.ly/3G6xq94 Engagement ≠ endorsement

Fortrea

fortrea.com

Fortrea (Nasdaq: FTRE) is a leading global clinical research organization (CRO) dedicated to providing innovative clinical development solutions to the life sciences industry. With over 30 years of clinical research experience, Fortrea has evolved from Covance and Labcorp into a pureplay CRO built for biotech, biopharma, medical device and diagnostic innovators. Fortrea collaborates with both emerging and established companies to deliver agile, fit-for-purpose full service (FSO), functional service (FSP) and hybrid solutions. Fortrea provides comprehensive Phase I-IV clinical trial management, clinical pharmacology, and consulting services, backed by deep experience in more than 20 therapeutic areas. Operating in approximately 100 countries, our diverse and talented team brings scientific rigor, operational excellence, and a strong investigator site network to every trial. By combining the best of our legacy experience with forward-thinking innovation, Fortrea brings predictability to clinical trial execution and helps transform aspirations into outcomes. Together, exceptional is possible. Learn more at Fortrea.com

Agilent Technologies

cb agilent.com

Agilent customers are finding new ways to treat cancer, ensure food, water, air, and medicine quality and safety, discover new drug treatments, research infectious diseases, and create alternative energy solutions for a greener planet. From start to finish, we have them covered with our vast product solutions and services portfolio. Around the world, Agilent’s people bring innovations, technologies, and services to the forefront of science. Our teams design and manufacture a wide array of advanced analytical, research, and diagnostic solutions and tools for use inside and outside laboratories. Additionally, the unique expertise of Agilent’s CrossLab and technical teams provides valuable insight and support to our customers, helping them fully optimize their laboratories and resources to better focus on what's important: bringing great science to life. In fiscal 2022, Agilent Technologies generated revenue of (US) $6.85 billion.

Eurofins

cb eurofins.com

Since 1987, Eurofins has grown from one laboratory in Nantes, France to over 65,000 staff across a network of independent companies in 60 countries, operating over 950 laboratories. Performing over 450 million tests every year, Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products, as well as providing innovative clinical diagnostic testing services, as one of the leading global emerging players in specialised clinical diagnostics testing. Ever since its IPO on the French stock exchange in 1997, Eurofins has been one of the fastest growing listed European companies.

bioMérieux

biomerieux.com

A family-owned company, bioMérieux has grown to become a world leader in the field of in vitro diagnostics. Our entrepreneurial adventure, begun over a century ago, is driven by an unrelenting commitment to improve public health worldwide. Since 1963, we've been paving the way in the field of in vitro diagnostics and have contributed greatly to improving public health and making the world a healthier place. The solutions that our teams imagine, develop and manufacture are key to enable healthcare professionals and industry players to make confident decisions to improve patient outcome and ensure consumer safety.

ICON plc

iconplc.com

Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality at all times. We offer a full range of consulting, development and commercialisation services from a global network of offices in 53 countries. We focus our innovation on the factors that are critical to our clients – reducing time to market, reducing cost, and increasing quality – and our global team of experts has extensive experience in a broad range of therapeutic areas.

Loading…

NEWS

Bioexpression & Fermentation Facility CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

May 10, 2022 07:00 AM

UGA’s Bioexpression & Fermentation Facility: Longtime BFF to Georgia’s bioeconomy

David Blum directs the Bioexpression and Fermentation Facility, which for more than 50 years has been serving UGA faculty and industry needs in...

Read Article

July 20, 2021 07:00 AM

Curia CEO seized 'huge open door' to biologics with back-to-back buyouts of LakePharma, Integrity Bio

Curia, the CDMO formerly known as Albany Molecular Research, had itself a busy week. Late last Sunday, the company re-named itself.

Read Article

July 15, 2021 07:00 AM

Curia, formerly Albany Molecular, acquires another pharma firm

Curia, which until recently was known as Albany Molecular Research, has entered into a...

Read Article

February 07, 2019 08:00 AM

Initiative to create coursework for cell manufacturing workers

Research teams at the University of Georgia and the University of Pennsylvania, along with four private firms, are taking part in an...

Read Article

January 21, 2014 08:00 AM

UGA researchers work to clone strong, high-quality sweetgum trees

UGA researchers are working to produce faster-growing sweetgum trees by growing embryogenic sweetgum cultures in bioreactors,...

Read Article

October 10, 2011 07:00 AM

Big plans

A small brick building tucked in behind the sprawling Davison Life Sciences Complex houses one of the busiest labs on campus.

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-61246

SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 8.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H).

Published

Date2026-07-22

Updated

Date2026-07-22

RISK INFORMATION (Score: 8.8)

cvss3

Base Score: 8.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

Impact Score

5.9

Exploitability

2.8

REFERENCES

https://www.oracle.com/security-alerts/cpujul2026.html

CVE-2026-60455

SUMMARY

Published

Date2026-07-22

Updated

Date2026-07-22

RISK INFORMATION (Score: 8.8)

cvss3

Base Score: 8.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

Impact Score

5.9

Exploitability

2.8

REFERENCES

https://www.oracle.com/security-alerts/cpujul2026.html

CVE-2026-60439

SUMMARY

Published

Date2026-07-22

Updated

Date2026-07-22

RISK INFORMATION (Score: 8.8)

cvss3

Base Score: 8.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

Impact Score

5.9

Exploitability

2.8

REFERENCES

https://www.oracle.com/security-alerts/cpujul2026.html

CVE-2026-60373

SUMMARY

Published

Date2026-07-22

Updated

Date2026-07-22

RISK INFORMATION (Score: 8.8)

cvss3

Base Score: 8.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

Impact Score

5.9

Exploitability

2.8

REFERENCES

https://www.oracle.com/security-alerts/cpujul2026.html

CVE-2026-60372

SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 9.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H).

Published

Date2026-07-22

Updated

Date2026-07-22

RISK INFORMATION (Score: 9.8)

cvss3

Base Score: 9.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

Impact Score

5.9

Exploitability

3.9

REFERENCES

https://www.oracle.com/security-alerts/cpujul2026.html

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…